The Shri Ahimsa Naturals IPO is scheduled to open for subscription from March 25, 2025 to March 27, 2025. This book-built issue seeks to raise ₹73.81 Crores, consisting of a fresh issue of 42.03 Lakh shares valued at ₹50.02 Crores and an offer for sale of 19.92 Lakh shares worth ₹23.79 Crores. The allotment date is expected to be March 28, 2025, with the listing date set for April 3, 2025 on the NSE SME platform.

The price band for the IPO is set at ₹113 to ₹119 per equity share, which will give the company a market capitalization of ₹277.62 Crores at the upper price band. The lot size for the IPO is 1,200 shares, requiring a minimum investment of ₹1,42,800 for retail investors. High-Net-Worth Individuals (HNIs) will need to invest ₹2,85,600 for 2 lots (2,400 shares).

Shri Ahimsa Naturals is a prominent player in the extraction and manufacturing of Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, with applications across industries such as food & beverage, nutraceuticals, cosmetics, and pharmaceuticals.

As of March 20, 2025, the Grey Market Premium (GMP) of the Shri Ahimsa Naturals IPO is ₹0, indicating that there are no expected listing gains. The GMP reflects market conditions and unorganized demand but should not be considered a reliable indicator of the final listing price.

The subscription status will be updated once the IPO opens on March 25, 2025. Investors can also check their allotment status from March 28, 2025, by visiting the registrar's website and entering their application number, PAN, or DP Client ID.

The objectives of the IPO include:

1. ₹3,500.00 Lakhs for investment in Shri Ahimsa Healthcare Private Limited (SAHPL), to set up a manufacturing facility in Sawarda, Jaipur, Rajasthan.
2. General corporate purposes.

Financial Performance: The company has shown consistent growth in revenues over the years. For the period ended Sep 30, 2024, the revenues stood at ₹5,894.23 Lakh, with an EBITDA of ₹1,438.88 Lakh and Profit After Tax (PAT) of ₹974.45 Lakh. These results indicate strong financial health and steady expansion.

For FY24, the pre-issue EPS stands at ₹10.19, with a post-issue EPS of ₹8.00. The P/E ratio is 11.68x pre-issue and 14.87x post-issue, which is considered fairly priced compared to the industry average. The ROCE for FY24 is 25.69%, and the ROE is 22.25%, indicating solid returns on capital and equity.

IPO Review and Conclusion: While the Shri Ahimsa Naturals IPO is priced reasonably with solid financial metrics, the Grey Market Premium suggests there may be no immediate listing gains. Given the fair valuation and consistent growth, investors should approach this IPO with caution if aiming for short-term listing gains. However, long-term investors looking for exposure to the herbal extract and nutraceutical sectors might find the company’s growth prospects appealing.

The Upcoming IPOs in this week and coming weeks are Arisinfra Solutions Limited, Desco Infratech Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited.

The Current active IPO are Rapid Fleet Management Services, Active Infrastructures Limited,Grand Continental Hotels.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.